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Introduction
Medically unexplained symptoms (MUS) are symptoms for which the origin remains unclear despite
adequate history taking, physical examination, and additional investigations.1 An estimated 3–11%
of patients visiting general practice repeatedly consult their GP for MUS.2,3 MUS exist along a con-
tinuum ranging from self-limiting symptoms, to recurrent and persistent symptoms, through to
symptom disorders.4 Although there are various terms for the condition, for example unexplained
physical symptoms, functional symptoms, or somatoform symptoms, we have chosen to use MUS in
this article because this is the most frequently used term. This review aims to address current prob-
lems with the management of undifferentiated MUS; specific syndromes within the MUS spectrum,
such as chronic fatigue syndrome and irritable bowel syndrome, are excluded from discussion.
Patients with persistent MUS suffer from their symptoms, are functionally impaired, and are at
risk of potentially harmful additional testing and treatment.5 Furthermore, these patients
commonly express dissatisfaction with the medical care they receive during their illness.6 They feel
stigmatised and not taken seriously.7 GPs often experience patients with persistent MUS as difficult
and frustrating to manage.8 In addition, MUS are associated with reduced health-related quality of
life, higher healthcare and social costs, and costs associated with lost productivity.9,10
The effects of many treatment strategies have been studied in recent decades. However, not all
interventions are acceptable or feasible in routine primary care. In the light of the central role of the
GP in managing MUS, we will discuss the importance of consultation skills and the effects of specific
treatments in primary care. We will do this by way of a narrative review using available national
guidelines and Cochrane Reviews in this field.
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Clinical guidelines on MUS in primary care
In recent years several guidelines on MUS have been published: a Dutch multidisciplinary
guideline (2010);11 a German multidisciplinary guideline (2012);12 Dutch13 and
Danish14 general practice guidelines (2013); and multidisciplinary UK guidance for health
professionals (2014).15 The Dutch and German multidisciplinary guidelines and the Danish GP guide-
line make use of the Grading of Recommendations Assessment, Development and Evaluation
(GRADE) method to link levels of evidence to the recommendations included in the
guidelines.16 The Dutch GP guideline and the multidisciplinary UK guidance for health professionals
do not report levels of evidence in line with GRADE recommendations. According to the guidelines
the following elements are important for the treatment of patients with MUS.
Doctor–patient relationship
All guidelines mentioned above specifically pay attention to the doctor–patient relationship and
incorporate specific sections on this issue. There is high-quality evidence that patients with MUS
present difficulties in the general practice encounter and challenge the GP–patient
relationship;13,14 they frequently evoke feelings of frustration and irritation in GPs who experience
difficulties in explaining MUS to patients. The Dutch multidisciplinary guideline states that a good
doctor–patient relationship is associated with patient satisfaction and improved health outcomes,
and is an important condition for a good treatment course.11 All guidelines recommend
the strengthening of the doctor–patient relationship, which can be achieved by doctors recognising
the patient’s illness, taking the patient and their symptoms seriously, and demonstrating empathy.
Doctor–patient communication
All guidelines emphasise the importance of doctor–patient communication. There is high-quality evi-
dence that good doctor–patient communication in the consultation is essential for the treatment of
MUS as patients seek a shared understanding of their symptoms.12 Guidelines recommend
using standard approaches to exploring symptoms, such as the ideas, concerns, and expectations
model, employing open questions. Consultations should aim to validate the patient’s distress and
provide a detailed insight into the patient’s biopsychosocial background, needed for a shared under-
standing of the symptoms. Based on lower levels of evidence, the Dutch GP guideline and the Ger-
man and UK guidelines specifically pay attention to the provision of a summary by the GP as a
communication tool.12,13 Such a summary should include the topics that have been discussed in the
consultation. It gives the patient the opportunity to check whether the GP understands the problem
and to add their perspective to it. The guidelines also state that explicit communication about
expected results of biomedical investigations is essential.11–15 When discussing treatment, the Dan-
ish guideline states that the GP should communicate with the patient in an open and accommodat-
ing manner, in which the advantages and disadvantages of further testing and treatment can be
discussed.14
Explanation of symptoms
Although this has not been tested specifically in randomised controlled trials (RCTs), all guidelines
state that it is important to provide a targeted and tangible explanation in the patient’s language
about the cause of their symptoms. Information obtained during the structured exploration of the
symptoms should be incorporated into this explanation. The UK guideline is the most explicit about
the value of providing explanations.15 It states that patients benefit from an ’explanation that makes
sense, removes any blame from the patient, and generates ideas about how to manage the symp-
toms’. The Danish guideline suggests that patients perceive biological explanatory models as specifi-
cally useful.14
A stepped-care approach
All guidelines recommend a stepped-care approach.
The Dutch, Danish, and German guidelines describe three stages of MUS severity, which lack
clear cut-off points. These stages of severity correspond with different management options using a
stepped-care approach (Box 1).11–14 The German guideline focuses on the risk of progression to
chronic MUS based on evidence from follow-up studies.12 Risk determinants for chronic MUS are:
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multiple symptoms; duration of symptoms; functional impairment; psychosocial stress; psychological
comorbidity; and experienced difficulties in the doctor–patient relationship.12
Based on good clinical practice, the Danish guideline recommends delivering proactive care and
making regular follow-up appointments at fixed intervals during the course of treatment in complex
cases.14 Furthermore, it suggests that it is important that one care provider, preferably the GP,
keeps control and coordinates the care process. The Dutch GP guideline states that this could also
be a social psychiatric nurse, psychologist, or occupational health physician.13
All guidelines state that the more severe or complex the symptoms and limitations, the more
intense and complex the treatment needed for patient recovery. The most severely affected patients
need a close collaboration between professionals with a divergent range of skills and expertise in
secondary or tertiary care (that is, the final step in the stepped-care approach).
Cochrane Reviews on MUS in primary care
Four recent Cochrane Reviews summarise the available evidence on the management of MUS in pri-
mary care. Van Dessel et al studied the efficacy of non-pharmacological (psychological and physical)
interventions for MUS in adults,17while Kleinstauber et al assessed the efficacy of pharmacological
interventions.18 Hoedeman et al assessed the effectiveness of consultation letters to support primary
care physicians in their management of patients with MUS.19 Finally, Rosendal et al aimed to assess
the clinical effectiveness of enhanced care interventions, delivered by professionals providing
frontline primary care for adults with MUS.20 Recently, these reviews have been summarised as an
illustration of the uncertainty in the management of MUS patients.21 In the sections that follow, we
will describe the evidence from these Cochrane Reviews in a narrative way. We first describe evi-
dence from efficacy trials involving specialised treatment, then evidence from effectiveness trials
conducted in routine primary care.
Box 1. Stepped-care approach in clinical guidelines for MUS
Dutch GP guideline Danish GP guideline
German multidisciplinary
guideline Dutch multidisciplinary guideline
Mild
MUS
. Psycho-
education
. (Self-)manage-
ment advice
. Shared time-
contingent plan
. Follow-up
Symptoms
and mild
functional
disorders
. Normalisation,
explanation,
biopsychosocial
approach
. Follow-up
Step
1
. General principles of
therapy (empathy,
watchful waiting,
acknowledgement of
the symptoms,
explanation)
. Therapy by GP or
medical specialist, or
psychosomatic pri-
mary health care
Mild MUS . Biopsychosocial
approach by GP
. Psycho-education
. Short-term CBT
Moderate
MUS
. Psychosomatic
physio/exercise
therapy
. Mental health
nurse
practitioner
. Social psychiat-
ric nurse
Moderate
functional
disorders
. Explanations and
TERM model
. Regular
consultations
. Cooperation
with specialist (in
charge of assess-
ment, treatment
plan, and
supervision)
Step
2
. Regular consultations
. Therapy by GP or
medical specialist
PLUS psychotherapy
. Pain as core symp-
tom: antidepressant
. Pain not as core
symptom: antidepres-
sant in case of psychi-
atric comorbidity
Moderate
MUS
. Case management
by medical special-
ist, psychiatrist or
GP
. Medication
(for comorbidity)
. CBT
Severe
MUS
. Multidisciplinary
team / treat-
ment centre
Severe
functional
disorders
. Specialist clinic
. Multidisciplinary
treatment
. CBT and GET
. Consider phar-
macological
treatment
Step
3
. Specialist clinic with
multidisciplinary
treatment
Severe
MUS
. CBT
. Treatment by a
multidisciplinary
team in tertiary
care
CBT = cognitive behavioural therapy. GET = graded exercise therapy. MUS = medically unexplained symptoms. TERM = The Extended Reatribution and Management
model.
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Effects of psychological interventions
In a Cochrane Review from 2014 the efficacy of psychological treatments for MUS in adults was
analysed.17 The meta-analysis comparing psychological therapy delivered in primary or secondary
care (hospital and outpatient clinics) with usual care or placement on a waiting list found that the use
of psychological therapy resulted in less severe symptoms at the end of the treatment. The
Cochrane Review also demonstrated that, in the 14 studies analysed, cognitive behavioural therapy
(CBT) delivered by specially-trained healthcare professionals in primary care or in specialised set-
tings, is more effective than usual care. CBT reduces symptom severity, but effect sizes are small.
However, effects seem to be sustained after 1 year of follow-up. Stratified analyses of other psycho-
logical treatment strategies (for example, problem solving therapy, behavioural therapy, mindful-
ness, or psychodynamic therapies) did not show significant effects based on a small number of
studies. We conclude that psychological treatments, more specifically CBT, provided by specially-
trained professionals reduce symptom severity in patients with MUS, but effect sizes are small.
Effects of physical interventions
Although many GPs are inclined to refer patients with MUS for active therapies such as walking, run-
ning, and exercising, the evidence of their efficacy is absent. The authors of a 2014 Cochrane Review
on non-pharmacological interventions found no trials on the efficacy of physical therapies, such as
running therapy, graded exercise or activation therapy, for patients with MUS.17
Effects of pharmacological interventions
A Cochrane Review from 2014 provides an overview of the current status of research on the efficacy
and acceptability of pharmacological treatments for patients with MUS.18 The meta-analysis is based
on 26 RCTs involving 2159 participants aged 18–64 years presenting with long-lasting MUS and sig-
nificant impairment of functioning. The follow-up period in the studies ranged between 2 and 12
weeks. The main results from this meta-analysis showed that:
1. there is no difference in efficacy between tricyclic antidepressants (TCAs) and placebo on the
severity of symptoms;
2. new-generation antidepressants such as selective serotonin reuptake inhibitors (SSRIs) and
serotonin and norepinephrine reuptake inhibitors (SNRIs) may have a moderate effect on
symptom severity versus placebo; and
3. natural products, for example herbal remedies such as St John’s wort, may reduce the severity
of symptoms and other secondary outcomes compared with placebo.
Comparisons in this meta-analysis are based on a limited number of studies with small numbers
of participants. Furthermore, participants were mainly recruited outside of primary care. The meth-
odological quality of included studies is low and the risk of bias high. Therefore, we conclude that
there is little evidence for the efficacy of medication for MUS in primary care.
Effects of consultation letters
A Cochrane Review from 2010 on the effectiveness of consultation letters to support primary care
physicians in their treatment of patients with MUS analysed six RCTs involving 449 patients.19 The
authors reported limited evidence for improved physical functioning, but lower medical costs for an
intervention consisting of screening by a psychiatrist followed by a letter providing the GP with
advice on patient treatment. Joint consultation by a psychiatrist and GP, followed by a letter with
advice for the GP, resulted in a slight reduction in the severity of the symptoms. However, all studies
were performed in the US, study populations were small, and the studies were of moderate quality.
Effects of enhanced primary care
Enhanced care entails treatment models applied within the primary care setting by frontline primary
care professionals instead of by trained therapists. It includes techniques of explanation, reattribu-
tion and some components of CBT. A Cochrane Review from 2013 reported on the outcomes from
six effectiveness studies20 and found that treatments varied from very brief interventions
delivered within a normal consultation to structured programmes of longer duration involving several
appointments. Findings of the trials were mixed. Trials of brief reattribution and related interventions
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within ordinary consultations did not show a benefit to patient outcomes, although the training GPs
received within the studies improved their communication skills, professional attitudes and confi-
dence when dealing with patients with MUS. Trials of more intensive interventions with repeated
consultations suggested clinically meaningful patient benefit, but only included small numbers of
patients; such interventions need to be tested in larger trials.20
Discussion
Summary
The available Cochrane Reviews provide some guidance for the management of patients with MUS
in primary care. The following were found with regard to patient outcomes:
1. the effectiveness of enhanced care by primary care professionals is currently limited;
2. the efficacy of psychological treatment provided by specialists is well documented and CBT is
the psychological treatment with the strongest current evidence;
3. the role of pharmacotherapy is very limited;
4. evidence for physical treatment is absent; and
5. the effectiveness of consultation letters is limited.
Although largely based on consensus, the guidelines provide GPs with greater insight. The follow-
ing specific communication skills are recommended: systematically exploring patient’s ideas, con-
cerns, and expectations, and providing a targeted and tangible explanation for their symptoms. If
patients have mild-to-moderate MUS, GPs should provide them with practical and constructive
advice that is easily applicable to their daily lives, but the guidelines provide limited guidance on
how to achieve this. Finally, guidelines advocate a stepped-care approach for all patients with MUS
in which the most severely affected patients benefit from a multidisciplinary approach. The severity
of the symptoms and the functional limitations guide the management options in the stepped-care
model.
Strengths and limitations
It is important to notice that we did not include evidence from specific syndromes such as irritable
bowel syndrome or chronic fatigue syndrome in this narrative review. A number of functional syn-
dromes have been researched and evidence from this area may further contribute to our current
knowledge about MUS in general.
Systematic reviews, and consequently guidelines based largely on such reviews, are most appro-
priate to address relatively simple questions about the effect of interventions on clearly defined con-
ditions. Systematic reviews and RCTs may be less appropriate in patients with MUS where
boundaries are ambiguous and patients heterogeneous. Other research methods are necessary to
generate new and important knowledge in this field.22 Moreover, as experienced practitioners,
many GPs have developed successful strategies for patients with MUS that others may learn from.23
While CBT delivered by specialists has been shown to be effective, application of CBT by primary
care professionals shows less effect. Regarding various implementations of reattribution techniques,
evidence for patient benefit when applied by primary care professionals in routine care is lacking,
but the techniques have not been tested in efficacy trials. An exploration of which techniques are
feasible to apply in routine care and how to integrate them in primary care deserves more attention
in future research.
Implications for clinical practice
The clinical guidelines do provide some guidance, but their evidence base is limited and several bar-
riers may prevent the application of the recommendations.
For example, GPs consider explanation and reassurance important in patients with MUS, but may
experience many difficulties in explaining symptoms constructively15 and providing patients with
specific advice and self-management strategies.24 As training in enhanced primary care techniques
leads to changes in GP attitudes and awareness of MUS,25 work is needed to translate the positive
effects on the GPs into better patient outcomes.
In order to overcome the clinical challenges more evidence is needed on:
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1. the effects of strengthening the doctor–patient relationship on the course and prognosis of
MUS;
2. the influence of specific consultation skills (for example, systematical exploration of patient
ideas, concerns, and expectations, providing a summary and a personalised explanation) in
consultations about MUS;
3. the effects of physical therapy for patients with MUS; and
4. ways to deliver psychological treatment more effectively in primary care.
In conclusion, current systematic reviews indicate that psychological treatment delivered by spe-
cialists, especially CBT, has the strongest evidence for patient benefit. Training GPs to deliver brief
reattribution type interventions in routine consultations improves their skills and attitudes but there
is no evidence of improved patient outcomes. Guidelines concur that doctor–patient communication
is key; they emphasise the importance of exploring patients’ ideas, concerns, and expectations, pro-
viding acceptable explanations and offering advice on symptom management. Severe and complex
cases should be managed in collaboration with specialists in a stepped-care approach.
Provenance
Commissioned; externally peer reviewed.
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